Zambia: maternal transmission at centre of $20m for malaria investment:
This article was originally published in Clinica
Executive Summary
Efforts to improve the control of malaria in Zambia have received a US$20m boost with an international development (IDA) grant from the World Bank. One of two priority areas (the other is related mainly to the distribution of preventive nets) will be to increase the number of pregnant women diagnosed and fully treated pre-term, across all 72 districts of the country. The target is to increase coverage from 45% to 55% by 2008.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.